TNFRSF8 and neoplasm: Since we studied different lymphoma types, tumor cells presented variable immunophenotypes, with some lymphomas having CD20-positive lymphoma cells and others having CD30-positive lymphoma cells, which makes comparing tumor–bystander cell contacts with fixed antibody combinations difficult.